U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07161635) titled 'Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs' on Sept. 02.
Brief Summary: The purpose of this study is to collect safety and performance data on two approved intraocular lenses (IOLs). This study will be conducted in participants who require cataract surgery in both eyes. The IOLs are designed to provide vision at far, arm's length, and near.
Study Start Date: Oct., 2025
Study Type: INTERVENTIONAL
Condition:
Aphakia
Presbyopia
Intervention:
DEVICE: Clareon PanOptix Pro/Pro Toric Trifocal IOL
Intraocular lens (IOL) placed into the lens capsule of the eye during cataract surgery. I...